Comparison of two protocols for controlled ovarian stimulation in infertile women undergoing assisted reproductive technology

Efficacy of low-dose human chorionic gonadotropin in late follicular phase of controlled ovarian stimulation using GnRH agonist protocol among infertile women undergoing assisted reproductive technology

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT201107286420N5

Enrollment

130

Registered

2011-09-01

Start date

2009-03-01

Completion date

Unknown

Last updated

2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility. Female infertility

Interventions

Intervention 1: The control group (n=62) receive standard long protocol and gonadotropins administration continue until the day of hCG injection (10000 IU) for final follicular maturation. Interventio

Eligibility

Sex/Gender

Female

Age

18 Years to 38 Years

Inclusion criteria

Inclusion criteria: Age<38 years Regular menstrual cycle (25-35 days) BMI <30 kg/m 2 Normal uterus and ovaries in vaginal ultrasound FSH<10IU/L

Exclusion criteria

Exclusion criteria: Severe endometriosis Polycystic ovarian syndrome History of pelvic surgery Azoospermia More than two IVF or ICSI cycle failures

Design outcomes

Primary

Measure	Time frame
Chemical pregnancy. Timepoint: 2 weeks. Method of measurement: BHCG serum.	—

Secondary

Measure	Time frame
Clinical pregnancy. Timepoint: 7 weeks after embryo transfer. Method of measurement: Sonography.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Maryam Eftekhar

Research and Clinical Center for Infertility

eftekhar@ssu.ac.ir+98 35 1824 7085

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026